Myositis, Myasthenia Gravis, Autoimmunity, Immune Checkpoint Inhibitors, Immune Checkpoint Blockade, Immune-Related Adverse Event, Acetylcholine Receptor Antibodies, Immune Checkpoint Inhibitors-Induced Myositis, Immune Checkpoint Inhibitors-Myasth
encephalitis, autoimmune encephalitis, immune checkpoint inhibitors, cancer immunotherapy, adverse events, neurological immune-related adverse events, paraneoplastic neurological syndromes, neural antibodies, biomarkers, prognostic factors, cancer